If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Luisa Guidi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Biosimilar Pharmaceuticals Medicine & Life Sciences
Inflammatory Bowel Diseases Medicine & Life Sciences
Italy Medicine & Life Sciences
Safety Medicine & Life Sciences
Crohn Disease Medicine & Life Sciences
Tumor Necrosis Factor-alpha Medicine & Life Sciences
Synovitis Medicine & Life Sciences
Drug Monitoring Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2018 2019

  • 21 Citations
  • 3 h-Index
  • 11 Article
  • 2 Review article

The PROSit cohort of infliximab biosimilar in IBD: A prolonged follow-up on the effectiveness and safety across Italy

Armuzzi, A., Fiorino, G., Variola, A., Manetti, N., Fries, W., Orlando, A., Maconi, G., Bossa, F., Cappello, M., Biancone, L., Cantoro, L., Costa, F., D'Incà, R., Lionetti, P., Principi, M., Castiglione, F., Annunziata, M. L., Di Sabatino, A., Di Girolamo, M., Terpin, M. M. & 43 others, Cortelezzi, C. C., Saibeni, S., Amato, A., Ardizzone, S., Guidi, L., Danese, S., Massella, A., Ventra, A., Rizzuto, G., Massari, A., Perri, F., Annese, V., Saettone, S., Tari, R., Petruzzellis, C., Meucci, G., Imperiali, G., Guglielmi, F. W., Mazzuoli, S., Caserta, L., Parodi, M. C., Colli, A., Ronchetti, A., Pugliese, D., Geccherle, A., Rogai, F., Milani, S., Renna, S., Cassinotti, A., Andriulli, A., Martino, G., Scrivo, B., Troncone, E., Kohn, A., Bertani, L., Lorenzon, G., Ghione, S., Nardone, O., Vecchi, M., Bertani, A., Bosani, M. A., Bezzio, C. & Salerno, R., 2019, In : Inflammatory Bowel Diseases. 25, 3, p. 568-579 12 p.

Research output: Contribution to journalArticle

The PROSit cohort of infliximab biosimilar in IBD: A prolonged follow-up on the effectiveness and safety across Italy

Armuzzi, A., Fiorino, G., Variola, A., Manetti, N., Fries, W., Orlando, A., Maconi, G., Bossa, F., Cappello, M., Biancone, L., Cantoro, L., Costa, F., D'Incà, R., Lionetti, P., Principi, M., Castiglione, F., Annunziata, M. L., Di Sabatino, A., Di Girolamo, M., Terpin, M. M. & 43 others, Cortelezzi, C. C., Saibeni, S., Amato, A., Ardizzone, S., Guidi, L., Danese, S., Massella, A., Ventra, A., Rizzuto, G., Massari, A., Perri, F., Annese, V., Saettone, S., Tari, R., Petruzzellis, C., Meucci, G., Imperiali, G., Guglielmi, F. W., Mazzuoli, S., Caserta, L., Parodi, M. C., Colli, A., Ronchetti, A., Pugliese, D., Geccherle, A., Rogai, F., Milani, S., Renna, S., Cassinotti, A., Andriulli, A., Martino, G., Scrivo, B., Troncone, E., Kohn, A., Bertani, L., Lorenzon, G., Ghione, S., Nardone, O., Vecchi, M., Bertani, A., Bosani, M. A., Bezzio, C. & Salerno, R., 2019, In : Inflammatory Bowel Diseases. 25, 3, p. 568-579 12 p.

Research output: Contribution to journalArticle

Biosimilar Pharmaceuticals
Inflammatory Bowel Diseases
Italy
Safety
Crohn Disease

The PROSit cohort of infliximab biosimilar in IBD: A prolonged follow-up on the effectiveness and safety across Italy

Armuzzi, A., Fiorino, G., Variola, A., Manetti, N., Fries, W., Orlando, A., Maconi, G., Bossa, F., Cappello, M., Biancone, L., Cantoro, L., Costa, F., D'Incà, R., Lionetti, P., Principi, M., Castiglione, F., Annunziata, M. L., Di Sabatino, A., Di Girolamo, M., Terpin, M. M. & 43 others, Cortelezzi, C. C., Saibeni, S., Amato, A., Ardizzone, S., Guidi, L., Danese, S., Massella, A., Ventra, A., Rizzuto, G., Massari, A., Perri, F., Annese, V., Saettone, S., Tari, R., Petruzzellis, C., Meucci, G., Imperiali, G., Guglielmi, F. W., Mazzuoli, S., Caserta, L., Parodi, M. C., Colli, A., Ronchetti, A., Pugliese, D., Geccherle, A., Rogai, F., Milani, S., Renna, S., Cassinotti, A., Andriulli, A., Martino, G., Scrivo, B., Troncone, E., Kohn, A., Bertani, L., Lorenzon, G., Ghione, S., Nardone, O., Vecchi, M., Bertani, A., Bosani, M. A., Bezzio, C. & Salerno, R., 2019, In : Inflammatory Bowel Diseases. 25, 3, p. 568-579 12 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases

Felice, C., Pugliese, D., Papparella, L. G., Pizzolante, F., Onori, E., Gasbarrini, A., Rapaccini, G. L., Guidi, L. & Armuzzi, A., Sep 2 2018, In : Expert Review of Clinical Immunology. 14, 9, p. 751-759 9 p.

Research output: Contribution to journalReview article

Inflammatory Bowel Diseases
Joints
Interleukin-23
Therapeutics
Sulfasalazine
4 Citations (Scopus)

Harmful effects and potential benefits of anti-tumor necrosis factor (TNF)-α on the liver

Lopetuso, L. R., Mocci, G., Marzo, M., D’aversa, F., Rapaccini, G. L., Guidi, L., Armuzzi, A., Gasbarrini, A. & Papa, A., Aug 1 2018, In : International Journal of Molecular Sciences. 19, 8, 2199.

Research output: Contribution to journalReview article

necrosis
liver
Liver
tumors
Tumor Necrosis Factor-alpha